Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
About
Leap Therapeutics is a biopharmaceutical company dedicated to developing and commercializing targeted and immuno-oncology therapies for patients with cancer. Their pipeline includes several promising drug candidates, with a primary focus on agents that modulate the tumor microenvironment and enhance the body's immune response against cancer cells. Teams look it up for Biotech, HealthTech, Drug Discovery.
Frequently asked
What does Leap Therapeutics do?
Leap Therapeutics is a Biotech company that offers Services. Teams look it up for HealthTech, Drug Discovery, Clinical Trials. It is based in Cambridge, United States and was founded in 2017. Public records show $189M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Leap Therapeutics raised?
Leap Therapeutics has raised a total of $189M in funding.
Where is Leap Therapeutics headquartered?
Leap Therapeutics is headquartered in Cambridge, United States.
When was Leap Therapeutics founded?
Leap Therapeutics was founded in 2017.
What industry does Leap Therapeutics operate in?
Leap Therapeutics operates in Biotech, HealthTech, Drug Discovery, Clinical Trials, Oncology.
What is Leap Therapeutics's current status?
Leap Therapeutics's current operating status is: Inactive.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.